Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiac Rehabilitation | 26 | 2023 | 55 | 12.340 |
Why?
|
Heart Diseases | 10 | 2022 | 178 | 3.920 |
Why?
|
Hospitalization | 16 | 2023 | 1118 | 3.060 |
Why?
|
Smoking Cessation | 10 | 2019 | 554 | 2.550 |
Why?
|
Patient Compliance | 5 | 2019 | 333 | 2.170 |
Why?
|
Cardiovascular Diseases | 6 | 2023 | 687 | 2.160 |
Why?
|
Patient Acceptance of Health Care | 5 | 2019 | 420 | 1.910 |
Why?
|
Inpatients | 7 | 2023 | 266 | 1.800 |
Why?
|
Heart Valve Prosthesis Implantation | 4 | 2017 | 62 | 1.790 |
Why?
|
Cardiac Surgical Procedures | 3 | 2021 | 126 | 1.780 |
Why?
|
Exercise Test | 5 | 2022 | 193 | 1.670 |
Why?
|
Exercise Therapy | 7 | 2022 | 76 | 1.620 |
Why?
|
Outpatients | 7 | 2019 | 120 | 1.620 |
Why?
|
Cardiology | 6 | 2018 | 79 | 1.580 |
Why?
|
Coronary Artery Bypass | 5 | 2022 | 203 | 1.450 |
Why?
|
Echocardiography | 2 | 2023 | 322 | 1.360 |
Why?
|
Patient Participation | 4 | 2015 | 194 | 1.320 |
Why?
|
Patient Readmission | 6 | 2023 | 360 | 1.290 |
Why?
|
Coronary Disease | 3 | 2018 | 274 | 1.250 |
Why?
|
Humans | 69 | 2023 | 50800 | 1.240 |
Why?
|
Quality Improvement | 3 | 2018 | 363 | 1.230 |
Why?
|
Middle Aged | 30 | 2022 | 13539 | 1.100 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 7 | 2023 | 254 | 1.100 |
Why?
|
Heart Valve Diseases | 2 | 2016 | 53 | 1.100 |
Why?
|
Aged | 32 | 2023 | 11017 | 1.090 |
Why?
|
Smoking | 3 | 2019 | 749 | 1.070 |
Why?
|
Retrospective Studies | 22 | 2023 | 4761 | 1.050 |
Why?
|
Exercise | 8 | 2022 | 828 | 1.050 |
Why?
|
United States | 27 | 2023 | 6453 | 1.010 |
Why?
|
Preventive Medicine | 3 | 2015 | 27 | 1.010 |
Why?
|
Smokers | 3 | 2019 | 87 | 0.960 |
Why?
|
Nicotine | 2 | 2018 | 117 | 0.940 |
Why?
|
Coronary Artery Disease | 3 | 2014 | 230 | 0.930 |
Why?
|
Quality Indicators, Health Care | 4 | 2018 | 319 | 0.930 |
Why?
|
Percutaneous Coronary Intervention | 2 | 2022 | 108 | 0.910 |
Why?
|
Male | 35 | 2022 | 23363 | 0.910 |
Why?
|
Stroke Rehabilitation | 1 | 2022 | 34 | 0.880 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2022 | 13 | 0.870 |
Why?
|
Coronary Stenosis | 1 | 2022 | 31 | 0.860 |
Why?
|
Female | 37 | 2022 | 26652 | 0.850 |
Why?
|
Ambulatory Care | 2 | 2014 | 264 | 0.850 |
Why?
|
Fellowships and Scholarships | 2 | 2012 | 73 | 0.820 |
Why?
|
Electrocardiography | 1 | 2023 | 379 | 0.820 |
Why?
|
Weight Loss | 2 | 2014 | 269 | 0.810 |
Why?
|
Binge Drinking | 1 | 2021 | 23 | 0.810 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2020 | 36 | 0.770 |
Why?
|
Cost Sharing | 1 | 2019 | 12 | 0.750 |
Why?
|
Walking | 2 | 2023 | 205 | 0.740 |
Why?
|
Motivation | 2 | 2019 | 244 | 0.720 |
Why?
|
Patient Dropouts | 1 | 2019 | 49 | 0.720 |
Why?
|
Patient Education as Topic | 2 | 2020 | 449 | 0.700 |
Why?
|
Surveys and Questionnaires | 5 | 2022 | 2297 | 0.690 |
Why?
|
Tobacco Use Disorder | 2 | 2019 | 228 | 0.680 |
Why?
|
Myocardial Infarction | 3 | 2020 | 818 | 0.670 |
Why?
|
Alcoholism | 1 | 2021 | 271 | 0.670 |
Why?
|
Cardiology Service, Hospital | 1 | 2018 | 13 | 0.670 |
Why?
|
Atrial Fibrillation | 3 | 2020 | 599 | 0.660 |
Why?
|
Obesity | 3 | 2014 | 1141 | 0.630 |
Why?
|
Postoperative Complications | 3 | 2019 | 883 | 0.610 |
Why?
|
Lung Diseases | 1 | 2018 | 132 | 0.610 |
Why?
|
Heart Failure | 6 | 2022 | 669 | 0.600 |
Why?
|
Cardiac Valve Annuloplasty | 1 | 2016 | 5 | 0.600 |
Why?
|
Follow-Up Studies | 7 | 2019 | 1947 | 0.590 |
Why?
|
Mitral Valve | 1 | 2016 | 45 | 0.570 |
Why?
|
Practice Patterns, Physicians' | 2 | 2019 | 688 | 0.560 |
Why?
|
Decision Making | 1 | 2019 | 341 | 0.560 |
Why?
|
Patient Transfer | 1 | 2016 | 82 | 0.550 |
Why?
|
Telemedicine | 1 | 2019 | 249 | 0.540 |
Why?
|
Aortic Valve | 1 | 2016 | 94 | 0.530 |
Why?
|
Referral and Consultation | 4 | 2022 | 359 | 0.530 |
Why?
|
Stroke | 1 | 2022 | 930 | 0.510 |
Why?
|
Health Services Accessibility | 2 | 2019 | 461 | 0.510 |
Why?
|
Postoperative Care | 1 | 2014 | 92 | 0.510 |
Why?
|
Employment | 1 | 2015 | 123 | 0.510 |
Why?
|
Health Care Surveys | 1 | 2015 | 262 | 0.500 |
Why?
|
Patient Discharge | 3 | 2020 | 428 | 0.500 |
Why?
|
Physical Therapy Modalities | 1 | 2013 | 38 | 0.470 |
Why?
|
Aged, 80 and over | 12 | 2021 | 4245 | 0.460 |
Why?
|
Appointments and Schedules | 1 | 2012 | 38 | 0.450 |
Why?
|
Prescriptions | 2 | 2022 | 27 | 0.430 |
Why?
|
Exercise Tolerance | 2 | 2022 | 46 | 0.420 |
Why?
|
Medicare | 5 | 2023 | 493 | 0.420 |
Why?
|
Risk Assessment | 5 | 2021 | 1599 | 0.410 |
Why?
|
Guidelines as Topic | 1 | 2012 | 148 | 0.400 |
Why?
|
Adipose Tissue | 1 | 2013 | 283 | 0.380 |
Why?
|
Databases, Factual | 4 | 2018 | 729 | 0.380 |
Why?
|
Nurses | 2 | 2021 | 84 | 0.360 |
Why?
|
Time Factors | 6 | 2021 | 3163 | 0.360 |
Why?
|
Incidence | 3 | 2022 | 1128 | 0.350 |
Why?
|
Risk Factors | 8 | 2021 | 4362 | 0.340 |
Why?
|
Curriculum | 1 | 2012 | 495 | 0.340 |
Why?
|
Internship and Residency | 2 | 2012 | 617 | 0.330 |
Why?
|
Acute Disease | 3 | 2019 | 602 | 0.330 |
Why?
|
Nicotinic Agonists | 1 | 2008 | 39 | 0.330 |
Why?
|
Minnesota | 4 | 2016 | 20 | 0.330 |
Why?
|
Survival Rate | 4 | 2019 | 659 | 0.330 |
Why?
|
Counseling | 3 | 2021 | 393 | 0.330 |
Why?
|
Pilot Projects | 2 | 2022 | 775 | 0.320 |
Why?
|
Heart Rate | 2 | 2022 | 272 | 0.320 |
Why?
|
Reproducibility of Results | 5 | 2018 | 1317 | 0.320 |
Why?
|
Single-Blind Method | 3 | 2023 | 112 | 0.310 |
Why?
|
Smoking Prevention | 1 | 2008 | 178 | 0.310 |
Why?
|
Length of Stay | 4 | 2019 | 651 | 0.310 |
Why?
|
Hospital Mortality | 4 | 2019 | 767 | 0.290 |
Why?
|
Treatment Outcome | 7 | 2019 | 3966 | 0.290 |
Why?
|
Healthcare Disparities | 2 | 2020 | 276 | 0.270 |
Why?
|
Predictive Value of Tests | 3 | 2018 | 838 | 0.260 |
Why?
|
Prognosis | 4 | 2016 | 1271 | 0.260 |
Why?
|
Massachusetts | 2 | 2019 | 2000 | 0.240 |
Why?
|
Logistic Models | 2 | 2021 | 1160 | 0.220 |
Why?
|
Habits | 1 | 2022 | 21 | 0.220 |
Why?
|
Physical Exertion | 1 | 2022 | 73 | 0.220 |
Why?
|
Depression | 2 | 2018 | 765 | 0.210 |
Why?
|
Attitude | 1 | 2022 | 91 | 0.210 |
Why?
|
Oxygen Consumption | 1 | 2022 | 186 | 0.210 |
Why?
|
Alcohol-Related Disorders | 1 | 2021 | 32 | 0.200 |
Why?
|
Yoga | 1 | 2020 | 18 | 0.190 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 2204 | 0.190 |
Why?
|
Alcohol Drinking | 1 | 2022 | 271 | 0.190 |
Why?
|
Amiodarone | 1 | 2019 | 12 | 0.180 |
Why?
|
Atrial Flutter | 1 | 2019 | 15 | 0.180 |
Why?
|
Health Status | 1 | 2022 | 409 | 0.180 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2019 | 32 | 0.180 |
Why?
|
Proportional Hazards Models | 3 | 2021 | 614 | 0.180 |
Why?
|
Hospitals | 2 | 2023 | 329 | 0.180 |
Why?
|
Potassium | 1 | 2019 | 94 | 0.180 |
Why?
|
Postoperative Period | 2 | 2016 | 102 | 0.170 |
Why?
|
Telephone | 1 | 2019 | 113 | 0.170 |
Why?
|
Income | 1 | 2019 | 148 | 0.170 |
Why?
|
Wound Healing | 1 | 2019 | 149 | 0.170 |
Why?
|
Intention | 1 | 2018 | 58 | 0.160 |
Why?
|
Double-Blind Method | 1 | 2019 | 542 | 0.160 |
Why?
|
Surgical Procedures, Operative | 1 | 2019 | 141 | 0.160 |
Why?
|
Life Style | 1 | 2020 | 311 | 0.160 |
Why?
|
Dyspnea | 1 | 2018 | 65 | 0.160 |
Why?
|
Feasibility Studies | 1 | 2019 | 439 | 0.160 |
Why?
|
Pandemics | 1 | 2022 | 498 | 0.160 |
Why?
|
Plethysmography | 2 | 2014 | 14 | 0.150 |
Why?
|
Patient Satisfaction | 1 | 2019 | 367 | 0.150 |
Why?
|
Mass Screening | 1 | 2021 | 550 | 0.150 |
Why?
|
Activities of Daily Living | 1 | 2018 | 272 | 0.150 |
Why?
|
Emergencies | 1 | 2016 | 96 | 0.140 |
Why?
|
Myocardial Revascularization | 1 | 2016 | 67 | 0.140 |
Why?
|
Erythrocyte Transfusion | 1 | 2016 | 64 | 0.140 |
Why?
|
Physicians | 1 | 2021 | 409 | 0.140 |
Why?
|
Blood Pressure | 1 | 2018 | 490 | 0.140 |
Why?
|
Anxiety | 1 | 2018 | 343 | 0.140 |
Why?
|
Return to Work | 1 | 2015 | 19 | 0.140 |
Why?
|
Kidney Failure, Chronic | 1 | 2016 | 157 | 0.130 |
Why?
|
Skinfold Thickness | 1 | 2014 | 16 | 0.130 |
Why?
|
Advisory Committees | 1 | 2015 | 78 | 0.130 |
Why?
|
Stress, Psychological | 1 | 2018 | 383 | 0.130 |
Why?
|
Program Evaluation | 1 | 2017 | 465 | 0.130 |
Why?
|
Decision Support Techniques | 1 | 2016 | 152 | 0.130 |
Why?
|
Models, Cardiovascular | 1 | 2015 | 66 | 0.130 |
Why?
|
Morbidity | 1 | 2014 | 91 | 0.130 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2019 | 713 | 0.130 |
Why?
|
Forecasting | 1 | 2014 | 192 | 0.120 |
Why?
|
Adult | 6 | 2019 | 13437 | 0.120 |
Why?
|
Insurance Coverage | 1 | 2014 | 98 | 0.120 |
Why?
|
Body Mass Index | 2 | 2015 | 863 | 0.120 |
Why?
|
Insurance, Health | 1 | 2014 | 120 | 0.120 |
Why?
|
Propensity Score | 3 | 2020 | 106 | 0.120 |
Why?
|
Global Health | 1 | 2014 | 136 | 0.120 |
Why?
|
Waist Circumference | 1 | 2013 | 58 | 0.120 |
Why?
|
Comorbidity | 1 | 2016 | 999 | 0.120 |
Why?
|
Body Height | 1 | 2013 | 102 | 0.110 |
Why?
|
Young Adult | 3 | 2016 | 3736 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 347 | 0.110 |
Why?
|
Education, Medical, Graduate | 1 | 2015 | 259 | 0.110 |
Why?
|
Residence Characteristics | 1 | 2013 | 218 | 0.110 |
Why?
|
Adolescent | 3 | 2016 | 5346 | 0.100 |
Why?
|
Body Weight | 1 | 2013 | 387 | 0.100 |
Why?
|
Data Collection | 1 | 2012 | 368 | 0.100 |
Why?
|
Cohort Studies | 3 | 2021 | 2128 | 0.100 |
Why?
|
Physician's Role | 1 | 2011 | 121 | 0.090 |
Why?
|
American Heart Association | 2 | 2020 | 85 | 0.090 |
Why?
|
Chewing Gum | 1 | 2008 | 11 | 0.090 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2007 | 79 | 0.070 |
Why?
|
Aspirin | 1 | 2007 | 164 | 0.070 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2007 | 196 | 0.070 |
Why?
|
Societies, Medical | 2 | 2018 | 229 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2023 | 511 | 0.060 |
Why?
|
Benzimidazoles | 1 | 2004 | 50 | 0.060 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 80 | 0.060 |
Why?
|
Metabolic Equivalent | 1 | 2022 | 15 | 0.060 |
Why?
|
Patients | 1 | 2022 | 91 | 0.050 |
Why?
|
Evidence-Based Medicine | 2 | 2018 | 369 | 0.050 |
Why?
|
Caregivers | 1 | 2023 | 170 | 0.050 |
Why?
|
Drug Delivery Systems | 1 | 2004 | 273 | 0.050 |
Why?
|
Symptom Flare Up | 1 | 2020 | 11 | 0.050 |
Why?
|
Fee-for-Service Plans | 1 | 2020 | 56 | 0.050 |
Why?
|
Time-to-Treatment | 1 | 2020 | 77 | 0.050 |
Why?
|
DNA | 1 | 2004 | 723 | 0.050 |
Why?
|
Preoperative Period | 1 | 2019 | 57 | 0.050 |
Why?
|
Regression Analysis | 1 | 2020 | 455 | 0.040 |
Why?
|
Perception | 1 | 2020 | 165 | 0.040 |
Why?
|
Survival Analysis | 1 | 2020 | 469 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2004 | 591 | 0.040 |
Why?
|
Social Class | 1 | 2019 | 107 | 0.040 |
Why?
|
Data Warehousing | 1 | 2018 | 6 | 0.040 |
Why?
|
Qualitative Research | 1 | 2020 | 448 | 0.040 |
Why?
|
Consensus | 1 | 2018 | 133 | 0.040 |
Why?
|
Recovery of Function | 1 | 2018 | 196 | 0.040 |
Why?
|
Administrative Claims, Healthcare | 1 | 2016 | 10 | 0.040 |
Why?
|
Area Under Curve | 1 | 2016 | 108 | 0.040 |
Why?
|
Data Mining | 1 | 2016 | 41 | 0.040 |
Why?
|
ROC Curve | 1 | 2016 | 232 | 0.030 |
Why?
|
Disease Progression | 1 | 2019 | 744 | 0.030 |
Why?
|
Biomarkers | 1 | 2019 | 1003 | 0.030 |
Why?
|
Models, Statistical | 1 | 2016 | 295 | 0.030 |
Why?
|
Observer Variation | 1 | 2014 | 176 | 0.030 |
Why?
|
Medical Records | 1 | 2014 | 131 | 0.030 |
Why?
|
Electronic Health Records | 1 | 2016 | 297 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2013 | 132 | 0.030 |
Why?
|
Risk Reduction Behavior | 1 | 2013 | 126 | 0.030 |
Why?
|
Population Surveillance | 1 | 2014 | 201 | 0.030 |
Why?
|
Recurrence | 1 | 2014 | 498 | 0.030 |
Why?
|
Odds Ratio | 1 | 2014 | 764 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 965 | 0.030 |
Why?
|
Joint Commission on Accreditation of Healthcare Organizations | 1 | 2011 | 3 | 0.030 |
Why?
|
Wisconsin | 1 | 2011 | 14 | 0.030 |
Why?
|
Organizational Case Studies | 1 | 2011 | 43 | 0.030 |
Why?
|
Medical Audit | 1 | 2011 | 55 | 0.020 |
Why?
|
Disease Management | 1 | 2011 | 177 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 2011 | 230 | 0.020 |
Why?
|
Gram-Positive Bacteria | 1 | 2004 | 32 | 0.020 |
Why?
|
Drug Resistance, Bacterial | 1 | 2004 | 75 | 0.010 |
Why?
|
Ligands | 1 | 2004 | 390 | 0.010 |
Why?
|
Protein Binding | 1 | 2004 | 1474 | 0.010 |
Why?
|
Mice | 1 | 2004 | 9258 | 0.010 |
Why?
|
Animals | 1 | 2004 | 17887 | 0.000 |
Why?
|